Arcturus Therapeutics Holdings Inc. (ARCT) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$82.0M

Net Income/Loss (FY2025)

-$65.8M

Total Assets (FY2025)

$271.1M

Total Equity (FY2025)

$214.0M

Cash Flows from Operating Activities (FY2025)

-$74.3M

Source: Arcturus Therapeutics Holdings Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.